Quarterly report · Q3
2934.TEDINET S100QLF7
Period2022-06-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.7bn | 2022-06-01 → 2023-02-28 | Cons. | Net sales |
| Revenue | ¥11.9bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.4bn | 2021-06-01 → 2022-02-28 | Cons. | Net sales |
| Operating income | −¥690m | 2022-06-01 → 2023-02-28 | Cons. | Operating income |
| Operating income | ¥575m | 2021-06-01 → 2022-02-28 | Cons. | Operating income |
| Ordinary income | −¥709m | 2022-06-01 → 2023-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥712m | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥550m | 2021-06-01 → 2022-02-28 | Cons. | Ordinary income |
| Profit before tax | −¥710m | 2022-06-01 → 2023-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥550m | 2021-06-01 → 2022-02-28 | Cons. | Income before income taxes |
| Net income (owners) | −¥604m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥401m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥353m | 2021-06-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥559m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss |
| Net income | ¥353m | 2021-06-01 → 2022-02-28 | Cons. | Profit loss |
| Total assets | ¥7.8bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥6.1bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥5.5bn | at 2022-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.8bn | at 2023-02-28 | Cons. | Liabilities |
| Total liabilities | ¥1.9bn | at 2022-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.0bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥4.2bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥4.1bn | at 2022-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.0bn | at 2022-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-131.07 | 2022-06-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-54.37 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥90.64 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥80.6 | 2021-06-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.28 | 2021-12-01 → 2022-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥86.68 | 2021-06-01 → 2022-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥76.33 | 2021-06-01 → 2022-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 48.3% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.8% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.5% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 35
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-06-01 → 2023-02-28 | −¥139m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-06-01 → 2023-02-28 | −¥139m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2023-02-28 | −¥385m |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥4.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥3.9bn |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥139m |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥19m |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥3.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥3.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥252m |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥5.8bn |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥5.8bn |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥458,000 |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | −¥576m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2023-02-28 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2023-02-28 | ¥12.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥139m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2023-02-28 | −¥305m |
| Reconciling Itemsreconciling | revenue | 2021-06-01 → 2022-02-28 | −¥27m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-06-01 → 2022-02-28 | −¥27m |
| Reconciling Itemsreconciling | segment profit | 2021-06-01 → 2022-02-28 | −¥270m |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥2.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥2.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue intersegment | 2021-06-01 → 2022-02-28 | ¥27m |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | segment profit | 2021-06-01 → 2022-02-28 | ¥45m |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥2.6bn |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥2.6bn |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | segment profit | 2021-06-01 → 2022-02-28 | ¥666m |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥2.9bn |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥2.9bn |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | segment profit | 2021-06-01 → 2022-02-28 | ¥134m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-06-01 → 2022-02-28 | ¥7.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-06-01 → 2022-02-28 | ¥7.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-06-01 → 2022-02-28 | ¥27m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-06-01 → 2022-02-28 | ¥845m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 342
| Item | Context | Value | Unit |
|---|---|---|---|
| Comprehensive income | Prior1YTDDuration | 352531000 | JPY |
| Comprehensive income | CurrentYTDDuration | -558760000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 352531000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | -603631000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | － | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 44870000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E33800-000MedicalCareSalesBusinessReportableSegmentMember | 2894568000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E33800-000HealthcareSalesBusinessReportableSegmentMember | 2561971000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E33800-000HealthcareMarketingBusinessReportableSegmentMember | 1992274000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 7448815000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 7448815000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E33800-000MedicalCareSalesBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E33800-000HealthcareSalesBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E33800-000HealthcareMarketingBusinessReportableSegmentMember | 27214000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 27214000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -27214000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E33800-000MedicalCareSalesBusinessReportableSegmentMember | 2894568000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E33800-000HealthcareSalesBusinessReportableSegmentMember | 2561971000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E33800-000HealthcareMarketingBusinessReportableSegmentMember | 2019489000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 7476029000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -27214000 | JPY |
| Net sales | Prior1YTDDuration | 7448815000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E33800-000MedicalCareSalesBusinessReportableSegmentMember | 134356000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E33800-000HealthcareSalesBusinessReportableSegmentMember | 665760000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E33800-000HealthcareMarketingBusinessReportableSegmentMember | 45350000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 845466000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -269990000 | JPY |
| Operating income | Prior1YTDDuration | 575475000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E33800-000MedicalCareSalesBusinessReportableSegmentMember | 5843656000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E33800-000HealthcareSalesBusinessReportableSegmentMember | 3010136000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E33800-000HealthcareMarketingBusinessReportableSegmentMember | 3867176000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 12720969000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 12720969000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E33800-000MedicalCareSalesBusinessReportableSegmentMember | 458000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E33800-000HealthcareSalesBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E33800-000HealthcareMarketingBusinessReportableSegmentMember | 138837000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 139296000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -139296000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E33800-000MedicalCareSalesBusinessReportableSegmentMember | 5844115000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E33800-000HealthcareSalesBusinessReportableSegmentMember | 3010136000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E33800-000HealthcareMarketingBusinessReportableSegmentMember | 4006014000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 12860265000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -139296000 | JPY |
| Net sales | CurrentYTDDuration | 12720969000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E33800-000MedicalCareSalesBusinessReportableSegmentMember | -576157000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E33800-000HealthcareSalesBusinessReportableSegmentMember | 251689000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |